Arbor Capital Management Inc. ADV Lowers Position in CME Group Inc. (NASDAQ:CME)

Arbor Capital Management Inc. ADV trimmed its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 2.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,859 shares of the financial services provider’s stock after selling 182 shares during the quarter. CME Group accounts for approximately 1.4% of Arbor Capital Management Inc. ADV’s portfolio, making the stock its 26th largest holding. Arbor Capital Management Inc. ADV’s holdings in CME Group were worth $1,536,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CME. Vanguard Group Inc. boosted its holdings in shares of CME Group by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock worth $7,044,821,000 after buying an additional 215,044 shares during the last quarter. Capital International Investors increased its stake in CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after acquiring an additional 3,069,806 shares during the last quarter. Capital World Investors raised its holdings in shares of CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after acquiring an additional 1,172,575 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of CME Group by 2.9% during the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock valued at $1,462,678,000 after acquiring an additional 189,842 shares during the last quarter. Finally, Parnassus Investments LLC grew its holdings in shares of CME Group by 0.4% during the fourth quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock worth $1,193,551,000 after purchasing an additional 23,583 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.5 %

Shares of NASDAQ CME opened at $220.50 on Monday. The firm’s fifty day moving average is $203.51 and its 200 day moving average is $207.54. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $79.40 billion, a price-to-earnings ratio of 25.09, a PEG ratio of 8.92 and a beta of 0.55.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.30 earnings per share. On average, equities research analysts expect that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on CME shares. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Bank of America downgraded CME Group from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft increased their price objective on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Keefe, Bruyette & Woods boosted their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Finally, Piper Sandler reiterated an “overweight” rating and set a $225.00 price target on shares of CME Group in a research report on Tuesday, August 20th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $209.73.

Get Our Latest Stock Analysis on CME

Insiders Place Their Bets

In other news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the transaction, the director now owns 7,163 shares in the company, valued at approximately $1,399,936.72. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.